Global Embolotherapy Market Size, by Product (Embolic Agents, Support Devices), by Disease Indication (Cancer), by Procedure (Transcatheter Arterial Embolization), by End User & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1261441
  • |
  • Publishe Date : September 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

Embolotherapy is the deliberate blockage of an artery with an item such as a balloon inserted by a catheter for controlling or preventing hemorrhaging.

The Global Embolotherapy Market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. Growing target patient population coupled with rising patient preference for minimally invasive procedures will aid in driving the market growth. However, availability of substitutes might impede the market growth during the analysis period.

The global embolotherapy market is primarily segmented based on product, disease indication, procedure end user and region. Based on product the market is segmented into embolic agents and support devices. Based on disease indication the market is bifurcated into cancer, peripheral vascular disease neurological diseases, urological & nephrological disorders and gastrointestinal disorders. Further, based on procedure the market is segmented into transcatheter arterial embolization (transcatheter arterial radioembolization (TARE)/selective internal radiation therapy (SIRT) and transarterial chemoembolization (TACE). Based on end user the market is bifurcated into hospitals & clinics, ambulatory surgery centers and other end users. Based on region the market is segmented into North America, Europe, Asia Pacific, South America and Middle East & Africa.

On the basis of product, the market is split into:
* Embolic Agents
* Support Devices

On the basis of disease indication, the market is split into:
* Cancer
* Peripheral Vascular Disease
* Neurological Diseases
* Urological & Nephrological Disorders
* Gastrointestinal Disorders

On the basis of procedure, the market is split into:
* Transcatheter Arterial Embolization (TAE)
* Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)
* Transarterial Chemoembolization (TACE)

On the basis of end user, the market is split into:
* Hospitals & Clinics
* Ambulatory Surgery Centers
* Other End Users

Moreover, the market is classified based on regions and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* Abbott Laboratories
* Acandis GmbH
* Balt Extrusion
* Boston Scientific Corporation
* BTG PLC
* Cook Medical
* Johnson & Johnson
* Kaneka Corporation
* Medtronic PLC
* Meril Life Sciences Pvt., Ltd.

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, product, disease indication, procedure end user and market size and their forecast from 2015-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions product, disease indication, procedure end user and options with qualitative and quantitative information and facts

Target Audience:
* Embolotherapy Drug Manufacturers
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Embolotherapy Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Embolotherapy Market - Porter\'s Five Forces Analysis
4.4. Global Embolotherapy Market - PESTEL Analysis

5. Global Embolotherapy Market, by Product
5.1. Global Embolotherapy Market, Size and Forecast, 2015-2026
5.2. Global Embolotherapy Market, by Embolic Agents, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global Embolotherapy Market, by Support Devices, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026

6. Global Embolotherapy Market, by Disease Indication
6.1. Global Embolotherapy Market, Size and Forecast, 2015-2026
6.2. Global Embolotherapy Market, by Cancer, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global Embolotherapy Market, by Peripheral Vascular Disease, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026
6.4. Global Embolotherapy Market, by Neurological Diseases, 2015-2026
6.4.1. Key driving factors, trends and opportunities
6.4.2. Market size and forecast, 2015-2026
6.5. Global Embolotherapy Market, by Urological & Nephrological Disorders, 2015-2026
6.5.1. Key driving factors, trends and opportunities
6.5.2. Market size and forecast, 2015-2026
6.6. Global Embolotherapy Market, by Gastrointestinal Disorders, 2015-2026
6.6.1. Key driving factors, trends and opportunities
6.6.2. Market size and forecast, 2015-2026

7. Global Embolotherapy Market, by Procedure
7.1. Global Embolotherapy Market, Size and Forecast, 2015-2026
7.2. Global Embolotherapy Market, by Transcatheter Arterial Embolization (TAE), 2015-2026
7.2.1. Key driving factors, trends and opportunities
7.2.2. Market size and forecast, 2015-2026
7.3. Global Embolotherapy Market, by Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), 2015-2026
7.3.1. Key driving factors, trends and opportunities
7.3.2. Market size and forecast, 2015-2026
7.4. Global Embolotherapy Market, by Transarterial Chemoembolization (TACE), 2015-2026
7.4.1. Key driving factors, trends and opportunities
7.4.2. Market size and forecast, 2015-2026
7.5. Global Embolotherapy Market, by XX, 2015-2026
7.5.1. Key driving factors, trends and opportunities
7.5.2. Market size and forecast, 2015-2026

8. Global Embolotherapy Market, by Procedure
8.1. Global Embolotherapy Market, Size and Forecast, 2015-2026
8.2. Global Embolotherapy Market, by Hospitals & Clinics, 2015-2026
8.2.1. Key driving factors, trends and opportunities
8.2.2. Market size and forecast, 2015-2026
8.3. Global Embolotherapy Market, by Ambulatory Surgery Centers, 2015-2026
8.3.1. Key driving factors, trends and opportunities
8.3.2. Market size and forecast, 2015-2026
8.4. Global Embolotherapy Market, by Other End Users, 2015-2026
8.4.1. Key driving factors, trends and opportunities
8.4.2. Market size and forecast, 2015-2026

9. Global Embolotherapy Market by Region
9.1. Embolotherapy Market Regional Analysis, 2015-2026
9.2. Global Embolotherapy Market Revenue (USD Million) by Region, 2015-2026
9.3. North America Embolotherapy Market, 2015-2026
9.3.1. North America Embolotherapy Market Size and Forecast, 2015-2026
9.3.2. North America Embolotherapy Market by Country, 2015-2026
9.3.2.1. U.S. Embolotherapy Market, 2015-2026
9.3.2.2. Canada Embolotherapy Market, 2015-2026
9.4. Europe Embolotherapy Market, 2015-2026
9.4.1. Europe Embolotherapy Market Size and Forecast, 2015-2026
9.4.2. Europe Embolotherapy Market by Country, 2015-2026
9.4.2.1. Germany Embolotherapy Market, 2015-2026
9.4.2.2. France Embolotherapy Market, 2015-2026
9.4.2.3. Italy Embolotherapy Market, 2015-2026
9.4.2.4. UK Embolotherapy Market, 2015-2026
9.4.2.5. Spain Embolotherapy Market, 2015-2026
9.4.2.6. Rest of Europe Embolotherapy Market, 2015-2026
9.5. Asia Pacific Embolotherapy Market, 2015-2026
9.5.1. Asia Pacific Embolotherapy Market Size and Forecast, 2015-2026
9.5.2. Asia Pacific Embolotherapy Market by Country, 2015-2026
9.5.2.1. Japan Embolotherapy Market, 2015-2026
9.5.2.2. China Embolotherapy Market, 2015-2026
9.5.2.3. India Embolotherapy Market, 2015-2026
9.5.2.4. Rest of Asia Pacific Embolotherapy Market, 2015-2026
9.6. South America Embolotherapy Market, 2015-2026
9.6.1. South America Embolotherapy Market Size and Forecast, 2015-2026
9.6.2. South America Embolotherapy Market by Country, 2015-2026
9.6.2.1. Mexico Embolotherapy Market, 2015-2026
9.6.2.2. Brazil Embolotherapy Market, 2015-2026
9.6.2.3. Rest of South America Embolotherapy Market, 2015-2026
9.7. Middle East & Africa Embolotherapy Market, 2015-2026
9.7.1. Middle East & Africa Embolotherapy Market Size and Forecast, 2015-2026
9.7.2. Middle East & Africa Embolotherapy Market by Country, 2015-2026
9.7.2.1. Saudi Arabia Embolotherapy Market, 2015-2026
9.7.2.2. South Africa Embolotherapy Market, 2015-2026
9.7.2.3. Rest of Middle East & Africa Embolotherapy Market, 2015-2026

10. Competitive Landscape
10.1. Introduction
10.2. Market Share Analysis/Top Player Positioning, 2018

11. Company Profiles
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Product Benchmarking
11.1.4. Key Developments
11.2. Acandis GmbH
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Product Benchmarking
11.2.4. Key Developments
11.3. Balt Extrusion
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Product Benchmarking
11.3.4. Key Developments
11.4. Boston Scientific Corporation
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Product Benchmarking
11.4.4. Key Developments
11.5. BTG PLC
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Product Benchmarking
11.5.4. Key Developments
11.6. Cook Medical
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Product Benchmarking
11.6.4. Key Developments
11.7. Johnson & Johnson
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Product Benchmarking
11.7.4. Key Developments
11.8. Kaneka Corporation
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Product Benchmarking
11.8.4. Key Developments
11.9. Medtronic PLC
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Product Benchmarking
11.9.4. Key Developments
11.10. Meril Life Sciences Pvt., Ltd.
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Product Benchmarking
11.10.4. Key Developments

12. Key Insights

Content are not available

Choose License Type